SBC Medical Group Holdings Incorporated (NASDAQ:SBC – Free Report) – Equities researchers at Zacks Small Cap issued their Q3 2024 earnings per share (EPS) estimates for SBC Medical Group in a research report issued to clients and investors on Wednesday, October 23rd. Zacks Small Cap analyst M. Marin anticipates that the company will post earnings of $2.36 per share for the quarter. Zacks Small Cap also issued estimates for SBC Medical Group’s Q4 2024 earnings at $2.41 EPS, FY2024 earnings at $9.46 EPS and FY2025 earnings at $10.50 EPS.
SBC Medical Group Price Performance
Shares of SBC opened at $7.15 on Friday. SBC Medical Group has a one year low of $5.30 and a one year high of $36.52.
SBC Medical Group Company Profile
SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.
Further Reading
- Five stocks we like better than SBC Medical Group
- How to Invest in the Best Canadian Stocks
- Rocket Lab Stock Soars Higher: Can It Keep Climbing?
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- What is the S&P 500 and How It is Distinct from Other Indexes
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
Receive News & Ratings for SBC Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SBC Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.